Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-07-11
1998-11-24
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514565, 514614, 514654, 514657, A61K 3124, A61K 31195, A61K 3116, A61K 31135
Patent
active
058407561
ABSTRACT:
The present invention provides a pharmaceutical composition contains a thpeutically effective amount of L-DOPA ethyl ester and a carrier which comprises from 5.5 to 98.5% hydroxypropylmethyl cellulose, from 0.25 to 4.5% hydroxypropyl cellulose, and from 1 to 90% of a carboxyvinyl polymer.
REFERENCES:
patent: 4259314 (1981-03-01), Lowey
patent: 4424235 (1984-01-01), Sheth et al.
patent: 4680323 (1987-07-01), Lowey
patent: 5354885 (1994-10-01), Milman et al.
patent: 5607969 (1997-03-01), Milman et al.
Atlas Dafna
Cohen Sasson
Levy Ruth
Melamed Eldad
Shterman Nava
Jarvis William R. A.
Teva Pharmaceutical Industries Ltd.
White John P.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Pharmaceutical composition of L-DOPA ester does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of L-DOPA ester, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of L-DOPA ester will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702656